94 related articles for article (PubMed ID: 23155612)
1. Radionuclide treatment of metastatic disease in patients with differentiated thyroid carcinoma.
Mihailović J; Trifunović J
Vojnosanit Pregl; 2012 Oct; 69(10):899-903. PubMed ID: 23155612
[No Abstract] [Full Text] [Related]
2. Metastatic differentiated carcinoma of the thyroid and radioiodine.
Andrews JT; McGennisken MR
Australas Radiol; 1987 Feb; 31(1):41-6. PubMed ID: 3619809
[No Abstract] [Full Text] [Related]
3. Lack of efficacy of recombinant human thyrotropin versus thyroid hormone withdrawal for radioiodine therapy imaging in a patient with differentiated thyroid carcinoma lung metastases.
Taïeb D; Jacob T; Zotian E; Mundler O
Thyroid; 2004 Jun; 14(6):465-7. PubMed ID: 15242576
[TBL] [Abstract][Full Text] [Related]
4. Disseminated bone marrow metastases of insular thyroid carcinoma detected by radioiodine whole-body scintigraphy.
Rufini V; Salvatori M; Saletnich I; Luzi S; Fadda G; Shapiro B; Troncone L
J Nucl Med; 1996 Apr; 37(4):633-6. PubMed ID: 8691255
[TBL] [Abstract][Full Text] [Related]
5. [Procedural guideline for Iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma (version 5)].
Verburg FA; Schmidt M; Kreissl MC; Grünwald F; Lassmann M; Hänscheid H; Hohberg M; Luster M; Dietlein M
Nuklearmedizin; 2019 Jun; 58(3):228-241. PubMed ID: 31035298
[TBL] [Abstract][Full Text] [Related]
6. [Utility and limits of nuclear medicine in the follow-up of differentiated thyroid carcinoma].
Chiti A; Orunesu E; Rodari M
Ann Ital Chir; 2006; 77(3):215-22. PubMed ID: 17137036
[TBL] [Abstract][Full Text] [Related]
7. Conventional withdrawal of thyroid hormone before radioiodine therapy in differentiated thyroid carcinoma: how frequently are adequately raised TSH levels attained?
McLaughlin CM; Hunter SJ; Bell PM; McCance DR; Sheridan B; Atkinson AB
Clin Endocrinol (Oxf); 2008 Jul; 69(1):169-70. PubMed ID: 18042175
[No Abstract] [Full Text] [Related]
8. Differentiated thyroid carcinoma referred for radioiodine therapy.
Al-Balawi IA; Meir HM; Yousef MK; Nayel HA; Al-Mobarak MF
Saudi Med J; 2001 Jun; 22(6):497-503. PubMed ID: 11426239
[TBL] [Abstract][Full Text] [Related]
9. [Long-term results of iodine radioisotope therapy for lung metastasis of thyroid cancer].
Tsyb AF; Drozdovskiĭ BI; Proshin VV
Vopr Onkol; 1996; 42(3):73-5. PubMed ID: 8801748
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m tetrofosmin uptake in insular thyroid carcinoma. A comparison with iodine-131.
Degirmenci B; Aydin A; Comlekci A; Ozdogan O; Bekis R
Clin Nucl Med; 2003 May; 28(5):385-8. PubMed ID: 12702934
[TBL] [Abstract][Full Text] [Related]
11. Roentgen rounds #86. Metastatic Hürthle cell carcinoma.
Rames R; Kriegshauser L; Gilula LA
Orthop Rev; 1987 Jan; 16(1):60-3. PubMed ID: 3453959
[No Abstract] [Full Text] [Related]
12. Renal metastases from thyroid carcinoma.
Malhotra G; Asopa R; Rajan MG
Thyroid; 2010 Nov; 20(11):1321; author reply 321-2. PubMed ID: 21062198
[No Abstract] [Full Text] [Related]
13. [Iodine uptake in the chest in the follow-up of well-differentiated thyroid cancer].
García Alonso MP; Balsa Bretón MA; Paniagua Correa C; Castillejos Rodríguez L; Penín González FJ; Elviro Peña R; Ortega Valle A; Mariana Monguía A; Vásquez Tineo SI; Mendoza Paulini A; Pey Illera C
Rev Esp Med Nucl; 2011; 30(1):24-8. PubMed ID: 20863596
[TBL] [Abstract][Full Text] [Related]
14. [Radioisotope-storing metastases of a medullary thyroid carcinoma].
Becker W; Börner W
Dtsch Med Wochenschr; 1987 Nov; 112(47):1841. PubMed ID: 3678089
[No Abstract] [Full Text] [Related]
15. [Role of radioactive iodine in the treatment of differentiated thyroid cancer: physiopathological basis, results, considerations from the viewpoint of radioprotection].
Frühling J
Bull Mem Acad R Med Belg; 1994; 149(3-4):195-206; discussion 206-8. PubMed ID: 7841930
[TBL] [Abstract][Full Text] [Related]
16. The place of ionizing radiation in the treatment of thyroid carcinoma.
Millburn L; Ameen D
Otolaryngol Clin North Am; 1980 Feb; 13(1):109-13. PubMed ID: 7366995
[TBL] [Abstract][Full Text] [Related]
17. [Metabolic therapy with radioiodine of differentiated thyroid tumor].
Bestagno M; Campagnari G
Minerva Med; 1986 Nov; 77(44):2113-6. PubMed ID: 3785727
[No Abstract] [Full Text] [Related]
18. The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
Robbins RJ; Schlumberger MJ
J Nucl Med; 2005 Jan; 46 Suppl 1():28S-37S. PubMed ID: 15653649
[TBL] [Abstract][Full Text] [Related]
19. [Radioiodine treatment of differentiated thyroid carcinomas: residual ablation].
Konrády A
Orv Hetil; 2002 Jun; 143(25):1557; author reply. PubMed ID: 12577410
[No Abstract] [Full Text] [Related]
20. Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma.
Koong SS; Reynolds JC; Movius EG; Keenan AM; Ain KB; Lakshmanan MC; Robbins J
J Clin Endocrinol Metab; 1999 Mar; 84(3):912-6. PubMed ID: 10084570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
